...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: it's easy to see how the market has trouble wrapping its head around the Science

Failed P3 notwithstanding, another BTD on CKD, coupled with the hope of improved eGFR data, plus a solid partnering deal with a BP will do a lot to not only help legitimize the science but also move the pps in anticipation of a potential buyout.  I say stay tuned.......

Share
New Message
Please login to post a reply